December 28, 2025 a 05:00 pm
CLX: Analysts Ratings - The Clorox Company
The Clorox Company, a leader in consumer and professional products, has a diversified portfolio touching various sectors like Health and Wellness, Household, Lifestyle, and International. Recent analyst ratings suggest a cautious stance with a dominant 'Hold' position, reflecting a period of stability and gradual improvement. Despite challenges, Clorox's established market presence provides a strong resilience foundation.
Historical Stock Grades
| Recommendation | Count | Score |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 2 | |
| Hold | 13 | |
| Sell | 2 | |
| Strong Sell | 2 |
Sentiment Development
Over the past months, there has been a notably stable sentiment regarding CLX. The 'Hold' category consistently dominates, suggesting analysts are exercising caution amid potential uncertainties. Despite slight fluctuations, 'Strong Buy' and 'Buy' categories remain relatively constant, indicating a steady but cautious optimism.
- The total number of ratings has remained relatively stable, with the majority settling on 'Hold'.
- Minimal movement in 'Strong Buy' recommendations, often between 0 to 2 over the months.
- Little volatility observed in 'Sell' and 'Strong Sell' categories, maintaining consistency.
Percentage Trends
The percentage trends show a clear preference towards 'Hold' recommendations, signaling moderate confidence in the stock. As market conditions shift, analysts might reassess their positions to reflect changing market circumstances.
- 'Hold' commands approximately 65% of the ratings, illustrating a strong inclination towards steadiness.
- 'Strong Buy' remains below 10%, reflecting cautious optimism.
- Over 10% of the ratings denote 'Sell' positions, hinting at some pessimism.
- Noticeable shift from more 'Buy' to 'Hold' recommendations, reflecting increased conservatism over the past year.
Latest Analyst Recommendations
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-12-17 | Neutral | Neutral | Citigroup |
| 2025-11-04 | Neutral | Neutral | JP Morgan |
| 2025-11-04 | Equal Weight | Equal Weight | Morgan Stanley |
| 2025-11-04 | Equal Weight | Equal Weight | Wells Fargo |
| 2025-11-04 | Neutral | Neutral | Citigroup |
Analyst Recommendations with Change of Opinion
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-01-07 | Equal Weight | Underweight | Wells Fargo |
| 2024-11-06 | Hold | Sell | TD Cowen |
| 2024-10-01 | Buy | Hold | Jefferies |
| 2024-04-02 | Neutral | Buy | Citigroup |
| 2024-03-26 | Hold | Underperform | Jefferies |
Interpretation
The dominant 'Hold' sentiment reflects market caution, underscoring a neutral outlook amidst stable product demand in Clorox’s diverse segments. Analysts appear indecisive, likely due to external market factors or internal company performance. The stability in recommendations hints at a balanced view of risks and rewards. However, the absence of 'Strong Buy' signals might indicate hesitation towards aggressive positive outlooks.
Conclusion
Overall, The Clorox Company presents a stable investment opportunity with moderate risks. Analyst sentiment suggests a wait-and-see approach amidst market volatility. The 'Hold' consensus illuminates a gradual stance, while a shift towards more conservative ratings over time underscores the need for cautious optimism. Investors should remain vigilant of upcoming market trends and Clorox's strategic pivots to capitalize on potential growth and mitigate risks.